Cellular senescence: mechanisms, reversibility and research program (v3.1)

A broadened, traceable narrative synthesis on cellular senescence: what it is, the causal mechanisms that initiate and maintain it, how it is measured, and which interventions (senolytics, senomorphics, immune clearance, partial reprogramming, circulating factors) can slow or reverse its effects. It covers literature up to November 2026, including 2025-2026 human trials, negative results and retractions, with each claim marked [Verified], [Hypothesis] or [Unknown] and every reference checked by DOI. Short answer: some components of senescence can be modified in experimental models, but this dossier does not demonstrate a lasting, safe reversal of human aging; human signals remain limited by tissue and endpoint. The record contains the English document (PDF, 246 pages), the original French version (PDF, 255 pages), and reproducible research-team tools in English and French (scripts, data registers, sample-size calculations, SHA256 checksums; 34 automated checks pass). Use of AI: prepared with the assistance of artificial intelligence tools, under the editorial direction and responsibility of CEEDEXPRESS. Not medical advice: protocols are intended for qualified research teams under ethical and regulatory approval. No conflict of interest, no funding. Contact: [email protected]

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-09
DOI
https://doi.org/10.5281/zenodo.24085466
Primary Topic
Telomeres, Telomerase, and Senescence
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Cellular senescence: mechanisms, reversibility and research program (v3.1)

CEEDEXPRESS
Zenodo (CERN European Organization for Nuclear Research)
Telomeres, Telomerase, and Senescence
preprint

Cellular senescence: mechanisms, reversibility and research program (v3.1)

CEEDEXPRESS
preprint en

Abstract

A broadened, traceable narrative synthesis on cellular senescence: what it is, the causal mechanisms that initiate and maintain it, how it is measured, and which interventions (senolytics, senomorphics, immune clearance, partial reprogramming, circulating factors) can slow or reverse its effects. It covers literature up to November 2026, including 2025-2026 human trials, negative results and retractions, with each claim marked [Verified], [Hypothesis] or [Unknown] and every reference checked by DOI. Short answer: some components of senescence can be modified in experimental models, but this dossier does not demonstrate a lasting, safe reversal of human aging; human signals remain limited by tissue and endpoint. The record contains the English document (PDF, 246 pages), the original French version (PDF, 255 pages), and reproducible research-team tools in English and French (scripts, data registers, sample-size calculations, SHA256 checksums; 34 automated checks pass). Use of AI: prepared with the assistance of artificial intelligence tools, under the editorial direction and responsibility of CEEDEXPRESS. Not medical advice: protocols are intended for qualified research teams under ethical and regulatory approval. No conflict of interest, no funding. Contact: [email protected]

Zenodo (CERN European Organization for Nuclear Research)
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon